Surgery Partners, Inc. (SGRY) Misses Q2 EPS by 1c, Offers Guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $615.4 million versus the consensus estimate of $623.9 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2022 revenue of $2.5-2.6 billion, versus the consensus of $2.56 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
• Creatd files Form S-1 and reports Q1 2026 financial results